C反应蛋白可预测COVID-19的预后：它也是一个治疗靶点吗？ - Suppr

Suppr

超能文献

C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?

作者信息

Pepys Mark B

机构信息

Wolfson Drug Discovery Unit, UCL Royal Free Campus, London, UK.

出版信息

Eur Heart J. 2021 Jun 14;42(23):2280-2283. doi: 10.1093/eurheartj/ehab169.

DOI:10.1093/eurheartj/ehab169

PMID:33778886

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8083631/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6acb/8244632/05d6b3f35bc5/ehab169f1.jpg

相似文献

C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?

Eur Heart J. 2021 Jun 14;42(23):2280-2283. doi: 10.1093/eurheartj/ehab169.

Simple "Rule-of-6" Predicts Severe Coronavirus Disease 2019 (COVID-19).

Clin Infect Dis. 2021 May 18;72(10):1861-1862. doi: 10.1093/cid/ciaa938.

Letter to "C-reactive protein level predicts need for medical intervention in pregnant women with SARS-CoV2 infection: A retrospective study".

J Obstet Gynaecol Res. 2022 May;48(5):1285-1286. doi: 10.1111/jog.15207. Epub 2022 Mar 10.

Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19.

Clin Chem Lab Med. 2021 Aug 30;59(12):1988-1997. doi: 10.1515/cclm-2021-0694. Print 2021 Nov 25.

Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants.

Front Immunol. 2023 Jun 14;14:1213246. doi: 10.3389/fimmu.2023.1213246. eCollection 2023.

Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR.

Inflammopharmacology. 2022 Jun;30(3):883-894. doi: 10.1007/s10787-022-00951-x. Epub 2022 Mar 23.

Higher Levels of C-Reactive Protein and Ferritin in Patients with Overweight and Obesity and SARS-CoV-2-Related Pneumonia.

Obes Facts. 2021;14(5):543-549. doi: 10.1159/000517851. Epub 2021 Sep 3.

The Gradient of Immune/Inflammatory Response and COVID-19 Prognosis with Therapeutic Implications.

Front Immunol. 2021 Oct 29;12:739482. doi: 10.3389/fimmu.2021.739482. eCollection 2021.

A robust COVID-19 mortality prediction calculator based on Lymphocyte count, Urea, C-Reactive Protein, Age and Sex (LUCAS) with chest X-rays.

Sci Rep. 2022 Oct 29;12(1):18220. doi: 10.1038/s41598-022-21803-2.

Racial Disparities Between C-Reactive Protein and COVID-19 In-Hospital Outcomes.

Am J Med. 2022 Oct;135(10):e409. doi: 10.1016/j.amjmed.2022.02.017.

引用本文的文献

Pre-hospital oxygen therapy and saturation variability in COVID-19 patients with and without glucose metabolism disorders: part of the COLOS Study.

Sci Rep. 2024 Aug 20;14(1):19286. doi: 10.1038/s41598-024-70240-w.

Editorial: Biology of C-reactive protein.

Front Immunol. 2024 Jun 19;15:1445001. doi: 10.3389/fimmu.2024.1445001. eCollection 2024.

C-reactive protein: structure, function, regulation, and role in clinical diseases.

Front Immunol. 2024 Jun 14;15:1425168. doi: 10.3389/fimmu.2024.1425168. eCollection 2024.

Investigation of Serum Endocan Levels in SARS-CoV-2 Patients.

Int J Mol Sci. 2024 Mar 6;25(5):3042. doi: 10.3390/ijms25053042.

Kinetics of IL-6, C-reactive Protein and Fibrinogen Levels in COVID-19 Outpatients Who Evolved to Hypoxemia.

Clin Pathol. 2024 Jan 3;17:2632010X231222795. doi: 10.1177/2632010X231222795. eCollection 2024 Jan-Dec.

Comparative analysis of CRP as a biomarker of the inflammatory response intensity among common viral infections affecting the lungs: COVID-19 versus influenza A, influenza B and respiratory syncytial virus.

Clin Exp Med. 2023 Dec;23(8):5307-5313. doi: 10.1007/s10238-023-01176-0. Epub 2023 Aug 28.

Being Eaten Alive: How Energy-Deprived Cells Are Disposed of, Mediated by C-Reactive Protein-Including a Treatment Option.

Biomedicines. 2023 Aug 16;11(8):2279. doi: 10.3390/biomedicines11082279.

C-reactive protein: a target for therapy to reduce inflammation.

Front Immunol. 2023 Jul 26;14:1237729. doi: 10.3389/fimmu.2023.1237729. eCollection 2023.

Plasma markers of COVID-19 severity: a pilot study.

Respir Res. 2022 Dec 13;23(1):343. doi: 10.1186/s12931-022-02272-7.

A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein.

EMBO Mol Med. 2023 Jan 11;15(1):e16236. doi: 10.15252/emmm.202216236. Epub 2022 Dec 5.

本文引用的文献

C-reactive protein and clinical outcomes in patients with COVID-19.

Eur Heart J. 2021 Jun 14;42(23):2270-2279. doi: 10.1093/eurheartj/ehaa1103.

C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases.

EBioMedicine. 2017 Aug;22:133-142. doi: 10.1016/j.ebiom.2017.07.010. Epub 2017 Jul 13.

Selective apheresis of C-reactive protein: a new therapeutic option in myocardial infarction?

J Clin Apher. 2015 Feb;30(1):15-21. doi: 10.1002/jca.21344. Epub 2014 Jul 5.

Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models.

Mediators Inflamm. 2014;2014:353614. doi: 10.1155/2014/353614. Epub 2014 Apr 2.

Infusion of pharmaceutical-grade natural human C-reactive protein is not proinflammatory in healthy adult human volunteers.

Circ Res. 2014 Feb 14;114(4):672-6. doi: 10.1161/CIRCRESAHA.114.302770. Epub 2013 Dec 12.

C-reactive protein, fibrinogen, and cardiovascular disease prediction.

N Engl J Med. 2012 Oct 4;367(14):1310-20. doi: 10.1056/NEJMoa1107477.

Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.

J Immunol Methods. 2012 Oct 31;384(1-2):92-102. doi: 10.1016/j.jim.2012.07.013. Epub 2012 Jul 31.

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data.

BMJ. 2011 Feb 15;342:d548. doi: 10.1136/bmj.d548.

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.

Lancet. 2010 Jan 9;375(9709):132-40. doi: 10.1016/S0140-6736(09)61717-7. Epub 2009 Dec 22.

THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : II. ISOLATION AND PROPERTIES OF THE REACTIVE PROTEIN.

J Exp Med. 1941 Jan 31;73(2):183-90. doi: 10.1084/jem.73.2.183.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验